The White House is facing a challenge in steering away from vaccine skepticism, as Health Secretary Robert F. Kennedy Jr. has been overhauling the federal government’s approach to vaccines. While some Trump administration officials are eager to distance themselves from the topic, citing a December poll showing strong bipartisan support for the childhood vaccine schedule, Kennedy and his Make America Healthy Again allies are not backing down. The ongoing clash between the two movements is explored in a deep dive by STAT’s Daniel Payne and Chelsea Cirruzzo.
In another development, the Food and Drug Administration has released draft guidance hinting at the potential authorization of additional vape flavors for sale. This move has raised concerns among public health experts, who fear that new flavors like coffee, mint, and cinnamon could attract children and reverse the progress made in reducing youth e-cigarette usage. The debate over the benefits and risks of adding more vaping flavors is discussed in an article by STAT’s Sarah Todd.
A recent study published in Science highlights the discovery of an anomalous protein on the surface of cancer cells, which could serve as a promising immunotherapy target for solid tumors. The protein, Src, may offer a new avenue for developing medications to combat cancer cells. STAT’s Angus Chen provides an overview of the study, shedding light on why cancer cells exhibit this unique behavior and the potential implications for cancer treatment.
On the vaccine front, experts on an FDA advisory committee have recommended that flu vaccine manufacturers align next winter’s flu shots with the strains recommended by the World Health Organization. The committee also discussed the effectiveness of this year’s flu shots, with concerns raised about the emergence of a new strain of H3N2. Despite challenges in vaccine supply, the CDC reported moderate protection against hospitalization for vaccinated individuals. The evolving landscape of flu vaccine development is covered by STAT’s Helen Branswell.
In the realm of healthcare policy, a new poll by KFF indicates that Americans are giving more credit to the Trump administration over the Biden administration for efforts to lower drug prices. Trump’s TrumpRx initiative has garnered praise from 41% of Americans, while Biden’s law directing Medicare to negotiate lower prices has received less recognition. The poll results, along with insights from Mark Cuban on the partisan divide in acknowledging policy efforts, are detailed by STAT’s John Wilkerson.
Lastly, the intersection of surrealism and dementia care is explored by Jason Karlawish, a professor at the University of Pennsylvania’s Perelman School of Medicine. Surrealism, with its rejection of binary distinctions between reality and fantasy, offers a unique perspective on how caregivers can navigate the challenges of caring for individuals with advanced-stage dementia. Karlawish delves into how artistic techniques can help caregivers make sense of their patients’ experiences.
These diverse and insightful articles provide a glimpse into the complex landscape of healthcare, policy, and research, offering valuable perspectives on key issues shaping the future of medicine and public health.
